A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
Storm TrackerStorm Tracker layer: A dynamic view of storms showcasing Lightning, Dangerous Thunderstorm Alerts and Radar from the past 60 minutes RadarRadar layer: Past, current, and forecast radar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback